Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 23Active not recruiting 22Completed 4Suspended 2Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplasm Metastasis 1

Interventions

Specimen Handling 21Biopsy 14Magnetic Resonance Spectroscopy 13Cyclophosphamide 4Nivolumab 3Cetuximab 3Azacitidine 3venetoclax 2trastuzumab deruxtecan 2decitabine and cedazuridine drug combination 2X-Rays 2Vincristine 2Taxes 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Prednisone 2Practice Guidelines as Topic 2Lenalidomide 2Ipilimumab 2Etoposide 2Doxorubicin 2CTLA-4 Antigen 2(225)Ac-DOTA-c(RGDyK) 2spartalizumab 1relatlimab 1prednylidene 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Taxes × 30 days × Clear all
NCT05554380 2026-05-22

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

National Cancer Institute (NCI)

Phase 2 Suspended
33 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05685602 2026-05-18

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
43 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡